World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
43
Citations
7099
World Ranking
7294
National Ranking
3943

Edward S. Friedman publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Edward S. Friedman sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 112 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Edward S. Friedman D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Edward S. Friedman sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 43 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Edward S. Friedman is affiliated with the University of Pittsburgh in the United States. Their research primarily falls within the field of Medicine, with a focus on Psychiatry and Mental Health. Additional areas of study include Pharmacology, Cognitive Neuroscience, Experimental and Cognitive Psychology, and Sociology and Political Science.

The scientist's research topics cover a range of mental health and psychiatric conditions, with particular emphasis on bipolar disorder and treatment. Other notable topics include treatment of major depression, schizophrenia research and treatment, electroconvulsive therapy studies, functional brain connectivity studies, anxiety and depression, psychometrics, cognitive processes, and family support in illness.

Frequent publication venues include the Journal of Affective Disorders, NeuroImage Clinical, Acta Psychiatrica Scandinavica, Australian & New Zealand Journal of Psychiatry, and Psychiatry Research.

Their recent papers encompass the following works:

  • Response to SSRI intervention and amygdala activity during self-referential processing in major depressive disorder, 2020, NeuroImage Clinical
  • Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder, 2022, Acta Psychiatrica Scandinavica
  • Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response, 2021, Journal of Affective Disorders
  • Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changes, 2022, Australian & New Zealand Journal of Psychiatry
  • Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response, 2020, Journal of Affective Disorders

Collaborations are frequent with several researchers in the field, including Michael E. Thase, James H. Kocsis, Andrew A. Nierenberg, Ole Köhler-Forsberg, and Louisa G. Sylvia.

Best Publications

  • Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

    Gary S. Sachs;Andrew A. Nierenberg;Joseph R. Calabrese;Lauren B. Marangell

  • Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.

    Michael E. Thase;Edward S. Friedman;Melanie M. Biggs;Stephen R. Wisniewski

  • Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment.

    Michael E. Thase;Anne D. Simons;Janice McGeary;John F. Cahalane

  • Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics

    Greg J. Siegle;Wesley K. Thompson;Amanda Collier;Susan R. Berman

  • Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia

    Hader A Mansour;Michael E Talkowski;Joel Wood;Kodavali V Chowdari

  • Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial

    Steven D. Hollon;Richard C. Shelton;Stephen Wisniewski;Diane Warden

  • Remission Prognosis for Cognitive Therapy for Recurrent Depression Using the Pupil: Utility and Neural Correlates

    Greg J. Siegle;Stuart R. Steinhauer;Edward S. Friedman;Wesley S. Thompson

  • The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

    Martin B. Keller;Madhukar H. Trivedi;Michael E. Thase;Richard C. Shelton

  • Management of treatment-resistant depression: psychotherapeutic perspectives.

    Michael E. Thase;Edward S. Friedman;Robert H. Howland

  • Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)

    Louisa G. Sylvia;Richard C. Shelton;David E. Kemp;Emily E. Bernstein

  • Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.

    James M. Russell;Lorrin M. Koran;John Rush;Robert M.A. Hirschfeld

  • Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder.

    Louisa G. Sylvia;Edward S. Friedman;James H. Kocsis;Emily E. Bernstein

  • Preventing Depressive Relapse and Recurrence in Higher Risk Cognitive Therapy Responders: A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Matched Pill Placebo

    Robin B. Jarrett;Abu Minhajuddin;Howard Gershenfeld;Edward S. Friedman

  • Transition to mania during treatment of bipolar depression.

    Roy H Perlis;Michael J Ostacher;Joseph F Goldberg;David J Miklowitz

  • Cognitive reactivity, dysfunctional attitudes, and depressive relapse and recurrence in cognitive therapy responders.

    Robin B. Jarrett;Abu Minhajuddin;Patricia D. Borman;Lauren Dunlap

  • Treating antidepressant nonresponders with augmentation strategies: an overview.

    M E Thase;R H Howland;E S Friedman

  • Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.

    Andrew A. Nierenberg;Edward S. Friedman;Charles L. Bowden;Louisa G. Sylvia

  • General medical burden in bipolar disorder: Findings from the LiTMUS comparative effectiveness trial

    David E Kemp;L. G. Sylvia;Joseph R Calabrese;A. A. Nierenberg

  • Acceptability of second-step treatments to depressed outpatients: A STAR*D report

    Stephen R. Wisniewski;Maurizio Fava;Madhukar H. Trivedi;Michael E. Thase

  • Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients.

    M E Thase;S Dubé;K Bowler;R H Howland

  • Poor quality of life and functioning in bipolar disorder.

    Louisa G. Sylvia;Rebecca E. Montana;Thilo Deckersbach;Michael E. Thase

Frequent Co-Authors

Michael E. Thase
Michael E. Thase University of Pennsylvania
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Charles L. Bowden
Charles L. Bowden The University of Texas Health Science Center at San Antonio
Terence A. Ketter
Terence A. Ketter Stanford University
Louisa G. Sylvia
Louisa G. Sylvia Harvard University
Richard C. Shelton
Richard C. Shelton University of Alabama at Birmingham
Joseph R. Calabrese
Joseph R. Calabrese Case Western Reserve University
Thilo Deckersbach
Thilo Deckersbach Harvard University
Susan L. McElroy
Susan L. McElroy University of Cincinnati Medical Center
Melvin G. McInnis
Melvin G. McInnis University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in studying psychology in the USA, there are a range of related online degrees and career paths to consider—especially in the field of substance abuse counseling. Online psychology and counseling degrees provide flexible options for students aiming to enter these high-demand roles.

Becoming a substance abuse counselor is a rewarding career, requiring specialized training and certification that can vary by location. Curious about how to become a substance abuse counselor in Scottsdale? In Scottsdale, specific education and licensing steps are required to start working in the field.

Requirements might differ elsewhere—for example, you can learn about becoming a substance abuse counselor in Seattle or explore the Spokane substance abuse counselor certification requirements. Each region has its own regulations, coursework, and clinical experience needed for certification.

Interested in other cities? Find out more about St. Louis substance abuse counselor certification requirements to understand the pathway there. Online psychology degrees give you the core knowledge you'll need, while local certification ensures you meet community standards for practice.

Best Scientists Citing Edward S. Friedman

Trending Scientists

Recently Published Articles